glp-1 obesity drug updates today The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Use of diabetes and anti-obesity

349,350 This change suggests that liraglutide not only inhibits inflammation and cartilage degradation but may also promote the synthesis and accumulation of cartilage matrix, thereby helping to protect and repair joint cartilage

Other GLP-1R/GcgR dual-agonists, such as Pemvidutide (also known as ALT-801,) are also documented as undergoing clinical trials in which data has yet to be reported

Here enters the Gila monster, the largest lizard in North America

Ozempic is a once-a-week injection that starts at 0.25 milligrams (mg) and can be further increased by 0.5 mg every four weeks until you reach 2 mg doses

Assuming you meet clinical criteria for GLP-1 therapy (BMI of 30+, or 27+ with a related health condition), Found might be a good fit depending on your specific needs and situation